Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02610751 · ClinicalTrials.gov registry record
Maternal Smoking During Pregnancy and Female Fetal Testosterone Levels
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 80
- Enrollment target
NCT02610751 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 80 participants.
The verdict
NCT02610751 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
* The investigators hope their study will answer the question of whether or not fetal testosterone levels are increased in female newborns exposed to nicotine as a result of maternal smoking during pregnancy. Secondarily they plan to also evaluate maternal cotinine and testosterone levels and newborn anogenital distance, second digit to fourth digit (2D:4D) finger length ratio, newborn length and birth weight. * The investigators hope by performing this study, they will help to uncover the effect of tobacco exposure in utero on human female fetal testosterone levels, thus improving the counseling for tobacco use in pregnancy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-08-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02610751
The ClinicalTrials.gov registry entry for NCT02610751 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02610751 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02610751 about?
NCT02610751 is a clinical study titled "Maternal Smoking During Pregnancy and Female Fetal Testosterone Levels". * The investigators hope their study will answer the question of whether or not fetal testosterone levels are increased in female newborns exposed to nicotine as a result of maternal smoking during pregnancy. Secondarily they plan to also evaluate maternal cotinine and testosterone levels and newbor...
What is the current status of trial NCT02610751?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2016-01. Estimated completion is 2019-08-26.
Who is sponsoring clinical trial NCT02610751?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.